The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Epilepsy Patients May Have Poor Bone Health, High Fracture Risk

Epilepsy Patients May Have Poor Bone Health, High Fracture Risk

May 11, 2016 • By Michele B. Kaufman, PharmD, BCGP

  • Tweet
  • Email
Print-Friendly Version / Save PDF

GENERIC_Drugs_500x270In a recent research review, Sandra J. Petty, honorary research fellow at the Melbourne Brain Centre, The Florey Institute of Neuroscience and Mental Health, Parkville, Australia, and colleagues sought to better understand and define an increased fracture rate associated with epilepsy and its treatment.1 Studies in these patients have mostly varied in quality, making it difficult to determine definitive results. Many studies have shown that these patients have decreases in bone, developing osteoporosis and/or osteomalacia, along with a high prevalence of vitamin D insufficiency and deficiency. The risk of falling is higher for epileptics taking anti-seizure epileptic medications, who may suffer subsequent fractures after falling.

You Might Also Like
  • Baseline Bone Measures Predict Risk of Fragility Fracture in Postmenopausal
  • Serum Bone Markers CTX, PINP Not Linked with Hip Fracture Risk in Osteoporosis
  • Changes in Bone Markers Predict Fracture Reduction with Anti-Resorptive Drug
Also By This Author
  • New Gabapentinoid Warning Labels

Of note, epileptic patients also have the same risk factors as non-epileptics for fracture and osteoporosis, such as being smokers, having a family history, use of glucocorticoids, early menopause and low physical activity. Because of the many uses for anti-epileptic drugs, such as migraine, chronic pain and bipolar disorder, the association between anti-epileptic drugs, epilepsy and bone health warrant further investigation.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The investigators searched the medical literature for articles and abstracts pertaining to anti-epileptic and individual drugs, epilepsy, osteoporosis and bone fractures. They noted that, often, bone mineral density is not reported in epilepsy studies evaluating fracture. It is, therefore, recommended that longitudinal studies of bone microarchitecture be conducted to help determine bone quality associated with epilepsy and its treatment. In addition, larger research collaborations are recommended to advance understanding, particularly as it relates to examining the underlying genetics and pharmacogenomic associations of epilepsy and its treatment in connection with bone disease and fractures. Optimal management of bone health in epilepsy also requires further investigation and evaluation.


Michele B. Kaufman, PharmD, CGP, RPh, is a freelance medical writer based in New York City and a pharmacist at New York Presbyterian Lower Manhattan Hospital.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

References

  1. Petty SJ, Wilding H, Wark JD. Osteoporosis associated with epilepsy and the use of anti-epileptics—a review. Curr Osteoporos Rep. 2016 Apr;14(2):54–65. doi: 10.1007/s11914-016-0302-7.

Filed Under: Drug Updates Tagged With: anti-epletic drugs, bone, bone mineral density (BMD), Epilepsy, Fractures, Osteoporosis

You Might Also Like:
  • Baseline Bone Measures Predict Risk of Fragility Fracture in Postmenopausal
  • Serum Bone Markers CTX, PINP Not Linked with Hip Fracture Risk in Osteoporosis
  • Changes in Bone Markers Predict Fracture Reduction with Anti-Resorptive Drug
  • Osteoporosis Drugs Tied to Lower Fracture Risk & Health Costs

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)